Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fred Mermelstein

OTHER INVESTOR TYPE
1 INVESTMENTS
1 EXITS
Description

Mr. Fred Mermelstein serves as President at Javelin Pharmaceuticals. He is an Angel Investor. He completed his post-doctoral training supported by two grant awards; a National Institutes of Health fellowship and a Howard Hughes Medical Institute fellowship in the Department of Biochemistry at UMDNJ Robert Wood Johnson Medical School.

Primary Investor Type
Angel (individual)
Primary Office
  • 125 CambridgePark Drive
  • Cambridge, MA 02140
  • United States

Fred Mermelstein Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00 00000000000 27-May-2016 00000 00000 00000 Surgical Devices Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fred Mermelstein’s full profile, request a free trial.

Fred Mermelstein Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 00000000000 30-Apr-2018 0000000000 Completed
  • 2 buyers
To view this investor’s complete exits history, request access »

Fred Mermelstein Team (1)

Name Title Deals Funds Boards Office Contact
Info
Fred Mermelstein Ph.D Angel Investor Cambridge, MA

Fred Mermelstein Co-Investors (2)

Name With Exits Lead Partner
Alpine Meridian 1 0
Ulrich Kosciessa 0 0
To view this investor’s complete co-investor history, request access »